Women should seek prompt medical advice if they: Have been using retatrutide obtained from an unregulated or online source and experience any adverse symptoms Are pregnant, planning a pregnancy, or breastfeeding and have been offered or are considering retatrutide Have a history of thyroid cancer, pancreatitis, gallbladder disease, or eating disorders and are seeking weight management options Experience unexplained nausea, vomiting, severe abdominal pain, or changes in menstrual cycle while using any GLP-1-based therapy Red flag symptoms requiring urgent medical attention include: Severe or persistent abdominal pain (which may indicate pancreatitis or a gallbladder problem) call 999 or go to A&E if symptoms are severe or accompanied by systemic illness Signs of a serious allergic reaction such as facial swelling, difficulty breathing, or a widespread rash call 999 immediately Symptoms of hypoglycaemia (shakiness, sweating, confusion), particularly if taking other glucose-lowering medications Inability to keep fluids down, which may lead to dehydration and kidney problems seek same-day medical advice For women with obesity-related conditions such as PCOS, type 2 diabetes, or cardiovascular risk factors, a structured conversation with a GP or specialist is the safest starting point

As patients achieve weight loss with Semaglutide GLP-1, they will begin to observe not only the weight loss itself but also associated health benefits such as increased energy levels, improved mood, and better sleep
Gentle flexing and stretching of the muscles before and after exercise may help soothe occasional leg cramps, while some people find that applying heat or ice may offer temporary relief
All current clinical trials use subcutaneous injection only
JRNYS Wellness is not itself a healthcare provider
Staying active can also improve your GLP-1 levels and response by promoting insulin sensitivity (14, 6)